#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Plasma cell myeloma Rheumatoid arthritis Insulinoma Systemic mastocytosis T-cell lymphoma Aicardi-Goutieres syndrome Leukoencephalopathy Sickle cell anaemia Metachromatic leukodystrophy Idiopathic pulmonary fibrosis Pseudomyxoma peritonei Non-small cell lung cancer Thrombocytosis Haematological malignancy Familial haemophagocytic lymphohistiocytosis More trials…

    Learn about Rare Diseases

    Lymphangioma – Treatment Fragile X syndrome – Basic Information Hepatoblastoma Cytokine release syndrome – Trials in Disease Alport’s syndrome Thrombotic thrombocytopenic purpura – Diagnostics Congenital hypotransferrinaemia – Life with Disease Osteosarcoma metastatic Splenic marginal zone lymphoma – Life with Disease Prader-Willi syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lauromacrogol 400 Pamapimod Cart 19/22 T Cells Timbetasin Acetate [18F]Fluoro-Peg-Folate Enoxaparin Sodium Ammonium Chloride Allopurinol Sodium Clemizole Hydrochloride ALFENTANIL HYDROCHLORIDE Fluocinolone Acetonide Immunglobulin Ganciclovir Sodium Cefazolin Dexamethasone Acetate Mesna Dabigatran Etexilate Letermovir Mirtazapine Tasimelteon More therapies…

    Learn about Your Condition

    Peritoneal abscess Osteosarcoma metastatic Lysosomal storage disorder Myocarditis post infection Hot flush Bronchiolitis Lymphangiosarcoma Chronic coronary syndrome Angiosarcoma non-metastatic Von Willebrand's disease Bone marrow failure Genital infection female Streptococcal infection Solitary fibrous tumour Influenza More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Universitetssykehuset Nord-Norge HF

Universitetssykehuset Nord-Norge HF

Hansine Hansens Veg 67, Tromsø, 9019, Norway

Want to learn more about this study or check if you can participate? Contact us.

  • Comparison of ocrelizumab and rituximab treatment in adults with active relapsing-remitting multiple sclerosis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Multiple sclerosis
    Investigated Drugs:
    • Ocrelizumab
    • Rituximab
    Norway Sweden

  • Study on Short vs. Long Immunotherapy with Pembrolizumab and Nivolumab for Patients with High-Risk Skin Melanoma After Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Malignant melanoma
    Investigated Drugs:
    • Nivolumab
    • Pembrolizumab
    Finland Norway Sweden

  • Study on Tioguanine and Drug Combination for Patients Aged 0-45 with Newly Diagnosed Acute Lymphoblastic Leukemia

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Acute lymphocytic leukaemia
    Investigated Drugs:
    • Hydrocortisone Sodium Phosphate
    • Hydrocortisone Sodium Succinate
    • Inotuzumab Ozogamicin
    Belgium Denmark Estonia Finland France Germany +8

  • Study of Ambroxol Treatment in People with Early Stage or Mild Lewy Body Dementia

    Recruiting

    2 1
    Investigated Diseases:
    • Dementia with Lewy bodies
    Investigated Drugs:
    • Ambroxol Hydrochloride
    Norway

  • Study of diazepam and oxazepam in patients with benzodiazepine and opioid dependence who are receiving opioid agonist therapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Drug dependence
    Investigated Drugs:
    • Oxazepam
    • Diazepam
    Norway

  • Randomized Phase III trial of elecoglipron plus dapagliflozin on kidney outcomes and mortality in adults with chronic kidney disease

    Recruiting

    3 1 1
    Investigated Diseases:
    • Chronic kidney disease
    Investigated Drugs:
    • Azd5004
    • Dapagliflozin
    Bulgaria Czechia Denmark Finland France Germany +8

  • A study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn’s disease

    Recruiting

    3 1
    Investigated Drugs:
    • Duvakitug
    Austria Belgium Bulgaria Czechia France Germany +9

  • Study of Amlitelimab and BI 1015550 for Patients with Interstitial Lung Disease Due to Scleroderma

    Recruiting

    2 1
    Investigated Diseases:
    • Interstitial lung disease
    • Systemic scleroderma
    Investigated Drugs:
    • Bi 1015550
    • Amlitelimab
    Austria Belgium Denmark France Germany Italy +5

  • Phase II Randomized Trial of Adjuvant Durvalumab Immunotherapy After Neoadjuvant Chemoimmunotherapy in Patients With Resectable Non‑Small Cell Lung Cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Durvalumab
    Denmark Norway Sweden

  • Durvalumab after chemoradiation for patients with limited‑stage small cell lung cancer: a randomized trial of high‑dose versus standard thoracic radiation

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Small cell lung cancer limited stage
    Investigated Drugs:
    • Durvalumab
    Denmark Estonia Finland Germany Lithuania The Netherlands +2
Previous Page
1 … 5 6 7 8 9 … 13
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!